Moreover, we observed a statistically irrelevant tendency to the loss of PTEN expression occurrence in men, well- and moderately-differentiated tumors, primary T4 tumor, metastases to regional lymph nodes, and stage IV cancers. The gene discussed is PTEN; the disease is cancer.